Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Sep 7:9:942751.
doi: 10.3389/fmed.2022.942751. eCollection 2022.

Cryptococcal chest wall mass and rib osteomyelitis associated with the use of fingolimod: A case report and literature review

Affiliations
Case Reports

Cryptococcal chest wall mass and rib osteomyelitis associated with the use of fingolimod: A case report and literature review

Kent Carpenter et al. Front Med (Lausanne). .

Abstract

Being introduced in 2010, fingolimod was among the first oral therapies for relapsing multiple sclerosis (MS). Since that time, postmarketing surveillance has noted several case reports of various cryptococcal infections associated with fingolimod use. To date, approximately 15 such case reports have been published. We present the first and unique case of cryptococcal chest wall mass and rib osteomyelitis associated with fingolimod use. The patient presented with left-side chest pain and was found to have a lower left chest wall mass. Computerized tomography (CT) showed chest wall mass with the destruction of left 7th rib. Aspirate from the mass grew Cryptococcus neoformans. The isolate was serotype A. Fingolimod was stopped. The patient received liposomal amphotericin B for 2 weeks and started on fluconazole with a plan to continue for 6-12 months. The follow-up CT in 6 weeks showed a marked decrease in the size of the chest wall mass. In conclusion, our case highlights the atypical and aggressive form of cryptococcal infection possibly related to immunosuppression from fingolimod use.

Keywords: chest mass; cryptococcus; fingolimod; immunosuppression; osteomyelitis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Timeline of progression of illness and workup.
Figure 2
Figure 2
Imaging findings of chest wall mass and rib osteomyelitis. (A) Chest X-ray shows destruction of a rib. (B) Left chest wall mass (axial image). (C) Left chest wall mass (coronal view). Green arrow indicates the level of 7th rib fracture and mass.
Figure 3
Figure 3
Grocott's Methenamine Silver (GMS) stain of aspirate showing yeast forms. Objective: 200×.

Similar articles

Cited by

References

    1. Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, et al. . Sorrell, Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. Clin Infect Dis. (2010) 50:291–322. 10.1086/649858 - DOI - PMC - PubMed
    1. Decote-Ricardo D, LaRocque-de-Freitas IF, Rocha JDB, Nascimento DO, Nunes MP, et al. . Immunomodulatory role of capsular polysaccharides constituents of cryptococcus neoformans. Front Med. (2019) 6:129. 10.3389/fmed.2019.00129 - DOI - PMC - PubMed
    1. Diniz-Lima IF, Silva LM, Guimarães-de-Oliveira EB, Freire-de-Lima JC, Nascimento L, Morrot DO, et al. . Cryptococcus: history, epidemiology, and immune evasion. App Sci. (2022) 12:7086. 10.3390/app12147086 - DOI
    1. Hurtado JC, Castillo P, Fernandes F, Navarro M, Lovane L, Casas I, et al. . Mortality due to cryptococcus neoformans and cryptococcus gattii in low-income settings: an autopsy study. Sci Rep. (2019) 9:7493. 10.1038/s41598-019-43941-w - DOI - PMC - PubMed
    1. McFadden DC, Fries BC, Wang F, Casadevall A. Capsule structural heterogeneity and antigenic variation in cryptococcus neoformans. Eukaryot Cell. (2007) 6:1464–73. 10.1128/EC.00162-07 - DOI - PMC - PubMed

Publication types

LinkOut - more resources